🔥 Wednesday 5 November 2025 Wed, 5 Nov 2025

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Eagle Mountain Mining has received a non-binding indicative offer from Japan’s Nittetsu Mining to form a joint venture, injecting up to US$20 million to advance the Oracle Ridge copper project towards production by 2030.

Eagle Mountain Mining has secured a 12-month exclusive option to acquire the Oracle Ridge copper mine’s surface and mineral rights, positioning the company to potentially restart production on a resource containing 380,000 tons of copper.

Eagle Mountain Mining has taken significant steps to re-enter its Oracle Ridge copper project in Arizona through a strategic option agreement and a potential joint venture with Japan’s Nittetsu Mining. The deal promises to clear debt and fund early development, setting the stage for a medium-term production restart.

Verbrec Limited is streamlining its business by selling its Competency Training division for $11.5 million and acquiring Alliance Automation for $5.5 million, significantly boosting its digital and automation capabilities.

Verbrec Limited has agreed to acquire Alliance Automation for $5.5 million, significantly expanding its automation and digital capabilities while adding over $60 million in annual revenue.

Alice Queen Limited is updating its Horn Island Gold Project scoping study following a dramatic gold price increase, while engaging GBA Capital to explore financing options.

Santana Minerals has been granted a crucial 25-year mining permit for its Bendigo-Ophir Gold Project in New Zealand, paving the way for construction and gold production pending environmental approvals.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

EnergyX’s share price hike to US$11 signals renewed investor confidence and a lithium market rebound, increasing Pantera Lithium’s holding value by A$5.4 million.

RAS Technology Holdings has landed a significant contract to provide racing data and managed trading services for LeoVegas Group’s UK brands, including BetMGM UK, marking a strategic expansion into regulated markets.

Stakk Limited has reported a record-breaking $575,000 in revenue for October 2025, marking a staggering 146% increase from the previous month and nearly 9,500% growth year-over-year.

Impact Minerals is reigniting exploration at its vast Broken Hill project in NSW, leveraging rising metal prices and a proprietary multi-metal ratio to uncover high-grade platinum group metals and base metals.

Stavely Minerals reports promising new gold anomalies at its Fairview South prospect in western Victoria, setting the stage for imminent drilling to test extensions of high-grade mineralisation.

Peel Mining Limited reveals a robust high-grade resource base and ongoing exploration in the Cobar Basin, positioning itself for growth amid a dynamic regional mining landscape.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Austral Resources Australia Ltd has successfully completed a $40 million capital raise and is reinstated to ASX trading, positioning itself as a mid-tier copper producer with a dual-hub operation in Queensland.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

Koonenberry Gold has mobilised a second drill rig at its Enmore Gold Project in NSW, aiming to accelerate exploration along a promising 2km shear zone. Backed by strong funding, the company targets significant gold discoveries with a major follow-up drilling program underway.

Petratherm Limited reports robust metallurgical results from its Rosewood Titanium Heavy Mineral Sands Project, highlighting high-quality heavy mineral concentrates and promising recoveries that reinforce the project’s potential.

Kinetiko Energy has secured the first tranche of funding from FFS Refiners to accelerate development of a pilot LNG gas plant at Brakfontein, marking a key step in its multi-phase Project Alpha.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

Olympio Metals has raised $1.25 million to fund further exploration at its promising Bousquet Gold Project, following a maiden drilling program that intersected significant gold mineralisation in over 85% of holes.

Green Critical Minerals has signed a landmark MoU with South Korea’s Komex Carbon Corporation to co-develop and commercialize Very High Density (VHD) carbon products, marking GCM’s first international commercial agreement and a key step toward revenue generation in 2026.